Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct‐cannulated rats
暂无分享,去创建一个
[1] B. Tomczuk,et al. Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids , 2005 .
[2] R. Nagel,et al. Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor , 2000 .
[3] B. R. Smith,et al. Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics. , 1999, Bioorganic & medicinal chemistry letters.
[4] D. Cheresh,et al. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.
[5] D. Stupack,et al. A role for angiogenesis in rheumatoid arthritis. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[6] William F. Westlin,et al. A Peptidomimetic Antagonist of the Integrin αvβ3 Inhibits Leydig Cell Tumor Growth and the Development of Hypercalcemia of Malignancy , 1998 .
[7] M A Horton,et al. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. , 1997, The Journal of clinical investigation.
[8] M A Horton,et al. The alpha v beta 3 integrin "vitronectin receptor". , 1997, The international journal of biochemistry & cell biology.
[9] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Kessler,et al. Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. , 1994, Kidney international.
[11] S. Schwartz,et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. , 1994, Circulation research.
[12] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[13] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[14] S. Nesbitt,et al. Rat osteoclasts adhere to a wide range of rgd (arg‐gly‐asp) peptide‐containing proteins, including the bone sialoproteins and fibronectin, via a β3 integrin , 1992 .
[15] J. Eble. Integrins—A Versatile and Old Family of Cell Adhesion Molecules , 1997 .
[16] D. Cheresh,et al. Integrins, angiogenesis and vascular cell survival. , 1996, Chemistry & biology.
[17] A. Callow,et al. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA , 1994 .
[18] M. Ginsberg,et al. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. , 1991, Trends in biochemical sciences.